Cargando…

Direct oral anticoagulant therapy in patients with morbid obesity after intermediate- or high-risk pulmonary emboli

There is little reported on the efficacy and safety of direct oral anticoagulants (DOACs) in morbid obesity after venous thromboembolism (VTE). In this observational study, patients were followed up after intermediate- or high-risk pulmonary embolism (PE) at the University of Rochester Pulmonary Hyp...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lachant, Daniel J., Bach, Christina, Fe, Alexander, White, R. James, Lachant, Neil A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	European Respiratory Society 2021
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7861033/ https://www.ncbi.nlm.nih.gov/pubmed/33569503 http://dx.doi.org/10.1183/23120541.00554-2020

Ejemplares similares

Clinical and imaging outcomes after intermediate- or high-risk pulmonary embolus
por: Lachant, Daniel, et al.
Publicado: (2020)

Chronic therapeutic anticoagulation is associated with decreased thrombotic complications in SARS‐CoV‐2 infection
por: Lachant, Daniel J., et al.
Publicado: (2020)

Transitioning selexipag to oral treprostinil in patients with pulmonary artery hypertension
por: Arevalo, Carlo, et al.
Publicado: (2022)

Peak steps: Capacity for activity improves after adding approved therapy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2023)

Comparison of chest- and wrist-based actigraphy in pulmonary arterial hypertension
por: Lachant, Daniel, et al.
Publicado: (2021)

Cardiac Effort to Compare Clinic and Remote 6-Minute Walk Testing in Pulmonary Arterial Hypertension
por: Lachant, Daniel, et al.
Publicado: (2022)

Venous thromboembolism associates with SARS-CoV-2 more than seasonal influenza()
por: Lachant, Daniel, et al.
Publicado: (2021)

Meningococcemia Presenting as a Myocardial Infarction
por: Lachant, Daniel, et al.
Publicado: (2015)

Legionella micdadei: A Forgotten Etiology of Growing Cavitary Nodules: A Case Report and Literature Review
por: Lachant, Daniel, et al.
Publicado: (2015)

Chronic thromboembolic pulmonary hypertension is a clot you cannot swat
por: Bishop, G. Jay, et al.
Publicado: (2019)

Is it safe to withhold long-term anticoagulation therapy in patients with small pulmonary emboli diagnosed by SPECT scintigraphy?
por: Ghazvinian, R., et al.
Publicado: (2016)

Real life behaviour of direct oral anticoagulants in patients with nonvalvular atrial fibrillation and morbid obesity
por: Navarro-Almenzar, Begoña, et al.
Publicado: (2021)

Pharmacokinetics and Dosing Regimens of Direct Oral Anticoagulants in Morbidly Obese Patients: An Updated Literature Review
por: Zhao, Ying, et al.
Publicado: (2023)

CMV Encephalitis/Radiculitis: The Difficulty in Diagnosing in an Intubated Patient
por: Newcomb, Geoffrey, et al.
Publicado: (2019)

Asymptomatic necrotizing myositis in a young male with progressive interstitial lung disease
por: Baah, Samantha, et al.
Publicado: (2021)

A 39-Year-Old Pregnant Woman with Pulmonary Emboli on Long Term Anticoagulation
por: Mehta, Vishisht, et al.
Publicado: (2017)

Acute limb ischemia and aortic mural thrombosis as primary manifestations of severe acute respiratory syndrome coronavirus 2
por: Szeles, Andras, et al.
Publicado: (2021)

Methicillin Resistant Staphylococcus aureus Prostatic Abscess with Bacteremia
por: Lachant, Daniel J., et al.
Publicado: (2013)

Catheter directed thrombolysis combined with ECMO for massive pulmonary emboli
por: Lauren Lindsey, J., et al.
Publicado: (2018)

Effect on Morbidity and Mortality of Direct Oral Anticoagulants in Patients With COVID-19
por: Toubasi, Ahmad A.
Publicado: (2022)

Bilateral Pulmonary Emboli on Dabigatran
por: Clark, Emily, et al.
Publicado: (2021)

Heart rate monitoring improves clinical assessment during 6-min walk
por: Lachant, Daniel J., et al.
Publicado: (2020)

Efficacy and Safety of Direct Oral Anticoagulants in Venous Thromboembolism Compared to Traditional Anticoagulants in Morbidly Obese Patients: A Systematic Review and Meta-Analysis
por: Katel, Anjan, et al.
Publicado: (2021)

Pulmonary micro-tumor emboli resulting in paradoxical emboli: a case report
por: Morin-Thibault, Louis-Vincent, et al.
Publicado: (2018)

Pulmonary emboli following oral contraceptive misuse and long air travel
por: Kazemi, Toba, et al.
Publicado: (2012)

Rare Presentation of Deep Vein Thrombosis and Submassive Pulmonary Emboli Due to Hypercoagulable State With Supratherapeutic Anticoagulation
por: Rivera-Morales, Mark D, et al.
Publicado: (2021)

Administration of Direct Oral Anticoagulant Immediately after Unfractionated Heparin Bolus for the Treatment of Intermediate–High-Risk Pulmonary Thromboembolism
por: Hara, Nobuhiro, et al.
Publicado: (2020)

Direct Oral Anticoagulants for Pulmonary Embolism: Importance of Anatomical Extent
por: Brekelmans, Marjolein P. A., et al.
Publicado: (2018)

CT Pulmonary Angiography: Increasingly Diagnosing Less Severe Pulmonary Emboli
por: Schissler, Andrew J., et al.
Publicado: (2013)

Emboli
por: Hay, Walter
Publicado: (1871)

Heart Rate Expenditure Correlates with Right Ventricular Function
por: Lachant, Daniel J., et al.
Publicado: (2020)

Direct Visualization of Arterial Emboli in Moyamoya Syndrome
por: Shulman, Julie G., et al.
Publicado: (2017)

Direct oral anticoagulants in extremely obese patients: OK to use?
por: Moll, Stephan, et al.
Publicado: (2018)

Paget-Schroetter syndrome with bilateral pulmonary emboli
por: Glavich, Garrison, et al.
Publicado: (2017)

Two pulmonary emboli in a psych pod
por: King, Samantha A., et al.
Publicado: (2020)

Elasomeran: Bilateral pulmonary emboli: case report
Publicado: (2022)

Use of direct oral anticoagulants for chronic thromboembolic pulmonary hypertension
por: Gavilanes-Oleas, Francisca Alexandra, et al.
Publicado: (2018)

Retrospective Analysis of Direct-Acting Oral Anticoagulants (DOACs) Initiation Timing and Outcomes After Thrombolysis in High- and Intermediate-Risk Pulmonary Embolism
por: Wolfe, Adam, et al.
Publicado: (2023)

Direct Oral Anticoagulants or Standard Anticoagulant Therapy in Fragile Patients with Venous Thromboembolism
por: López-Núñez, Juan J., et al.
Publicado: (2019)

Arterial Emboli Complicating Cisplatin Therapy
por: Tait, Campbell D., et al.
Publicado: (2012)

Cannot write session to /tmp/vufind_sessions/sess_bg9qe4v1cgekkqs4rf779ajlu1